Last reviewed · How we verify
NCT04732013: NICEST
Noninvasive Chromosomal Screening for Embryo Selection Trial
trial testing No clinical intervention is planned; study is observational in Infertility in 120 participants. Status unknown.
4 September 2022
Quick facts
| Lead sponsor | Olive Fertility Centre |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 4 December 2020 |
| Primary completion | 4 September 2022 |
| Estimated completion | 4 December 2022 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- No clinical intervention is planned; study is observational
Conditions studied
- Infertility — all drugs for Infertility →
- Aneuploidy — all drugs for Aneuploidy →
Sponsor
Olive Fertility Centre
Who can join
Adults 21 to 35, any sex, with Infertility or Aneuploidy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine the diagnostic accuracy of non-invasive preimplantation genetic testing for aneuploidy (NI-PGT-A) for embryo selection.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A Mini-Review Regarding the Clinical Outcomes of In Vitro Fertilization (IVF) Following Pre-Implantation Genetic Testing (PGT)-Next Generation Sequencing (NGS) Approach.
Doroftei B, Ilie OD, Anton N, Armeanu T, et al · · 2022 · cited 10× · PMID 36010262 · DOI 10.3390/diagnostics12081911 -
A pilot study to investigate the clinically predictive values of copy number variations detected by next-generation sequencing of cell-free deoxyribonucleic acid in spent culture media.
Nakhuda G, Rodriguez S, Tormasi S, Welch C. · · 2024 · cited 7× · PMID 38382698 · DOI 10.1016/j.fertnstert.2024.02.030
Verify or expand the search:
- PubMed search for NCT04732013
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infertility
Currently open trials in the same condition.
- NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
- NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
- NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
- NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
Other Olive Fertility Centre trials
Trials by the same sponsor.
- NCT05493202 — Superovulation And Urinary Concentration of Estrone · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04732013 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Olive Fertility Centre
- Last refreshed: 21 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04732013.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing